1. |
Iung B, Baron G, Butchart EG, et al. A prospective survey of patients with valvular heart disease in Europe: the Euro Heart Survey on Valvular Heart Disease. Eur Heart J, 2003, 24(13): 1231-1243.
|
2. |
Cribier A, Eltchaninoff H, Bash A, et al. Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis-first human case description. Circulation, 2002, 106(24): 3006-3008.
|
3. |
Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol, 2004, 43(4): 698-703.
|
4. |
Webb JG, Chandavimol M, Thompson CR, et al. Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation, 2006, 113(6): 842-850.
|
5. |
Webb JG, Pasupati S, Humphries K, et al. Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation, 2007, 116(7): 755-763.
|
6. |
Vahanian A, Alfieri O, Al-Attar N, et al. Transcatheter valve implantation for patients with aortic stenosis: a position statement from the European Association of Cardio-Thoracic Surgery (EACTS) and the European Society of Cardiology (ESC), in collaboration with the European Association of Percu. Eur Heart J, 2008, 29(11): 1463-1470.
|
7. |
Walther T, Falk V, Kempfert J, et al. Transapical minimally invasive aortic valve implantation; the initial 50 patients. Eur J CardioThorac Surg, 2008, 33(6): 983-988.
|
8. |
Covello R, Landoni G, Michev I, et al. Percutaneous aortic valve implantation:the anesthesiologist perspective. HSR Proc Intensive Care Cardiovasc Anesth, 2009, 1(2): 28.
|
9. |
Covello R, Landoni G, Michev I, et al. Anesthetic management of percutaneous aortic valve implantation: focus on challenges encountered and proposed solutions. J Cardiothorac Vasc Anesth, 2009, 23(3): 280-285.
|
10. |
Covello RD, Landoni G, Zangrillo A. Anesthetic management of transcatheter aortic valve implantation. Curr Opin Anaesthesiol, 2011, 24(4): 417-425.
|
11. |
Dehédin B, Guinot PG, Ibrahim H, et al. Anesthesia and perioperative management of patients who undergo transfemoral transcatheter aortic valve implantation: an observational study of generalversus local/regional anesthesia in 125 consecutive patients. J Cardiothorac Vasc Anesth, 2011, 25(6): 1036-1043.
|
12. |
Cheung A, Ree R. Transcatheter aortic valve replacement. Anesthesiol Clin, 2008, 26(3): 465-479.
|
13. |
Webb JG, Pasupati S, Achtem L, et al. Rapid pacing to facilitate transcatheter prosthetic heart valve implantation. Catheterization and Cardiovascular Interventions, 2006, 68(2): 199-204.
|
14. |
Fassl J. Pro: transcatheter aortic valve implantation should be performed with general anesthesia. J Cardiothorac Vasc Anesth, 2012, 26(4): 733-735.
|
15. |
Franco A, Gerli C, Ruggeri L, et al. Anaesthetic management of transcatheter aortic valve implantation. Ann Card Anaesth, 2012, 15(1): 54-63.
|
16. |
Guarracino F, Landoni G. Con: transcatheter aortic valve implantation should not be performed under general anesthesia. J Cardiothorac Vasc Anesth, 2012, 26(4): 736-739.
|
17. |
Ruggeri L, Gerli C, Franco A, et al. Anesthetic management for percutaneous aortic valve implantation:an overview of worldwide experiences. HSR Proc Intensive Care Cardiovasc Anesth, 2012, 4(1): 40.
|
18. |
Bradic N, Husedzinovic I, Sutlic Z, et al. Anesthesiology management for the transcatheter aortic valve implantation. J Cardiothorac Surg, 2013, 8(Suppl 1): 317.
|
19. |
Bufton KA, Augoustides JG, Cobey FC. Anesthesia for transfemoral aortic valve replacement in North America and Europe. J Cardiothorac Vasc Anesth, 2013, 27(1): 46-49.
|
20. |
Grando TA, Sarmento-Leite R, Lunardi Prates PR, et al. Anesthetic management and complications of percutaneous aortic valve implantation. Rev Bras Anestesiol, 2013, 63(3): 279-286.
|
21. |
See TY, Tan HL, Hwang NC. Anaesthesia for transcatheter aortic valve implantation. Trends in Anaesthesia and Critical Care, 2013, 3(6): 295-301.
|
22. |
Conzen PF, Fischer S, Detter C, et al. Sevoflurane provides greater protection of the myocardium than propofol in patients undergoing off-pump coronary artery bypass surgery. J Am Soc Anesthesiol, 2003, 99(4): 826-833.
|
23. |
Nader ND, Li CM, Khadra WZ, et al. Anesthetic myocardial protection with sevoflurane. J Cardiothorac Vasc Anesth, 2004, 18(3): 269-274.
|
24. |
Symons JA, Myles PS. Myocardial protection with volatile anaesthetic agents during coronary artery bypass surgery: a meta-analysis. Br J Anaesth, 2006, 97(2): 127-136.
|
25. |
Billings FT, Kodali SK, Shanewise JS. Transcatheter aortic valve implantation: anesthetic considerations. Anesth Analg, 2009, 108(5): 1453-1462.
|
26. |
Guarracino F, Covello RD, Landoni GA, et al. Anesthetic management of transcatheter aortic valve implantation with transaxillary approach. J Cardiothorac Vasc Anesth, 2011, 25(3): 437-443.
|
27. |
Edrich T, Sadovnikoff N. Anesthesia for patients with severe chronic obstructive pulmonary disease. Curr Opin Anaesthesiol, 2010, 23(1): 18-24.
|
28. |
Masson JB, Kovac J, Schuler G, et al. Transcatheter aortic valve implantation review of the Nature, management, and avoidance of procedural complications. JACC Cardiovasc Interv, 2009, 2(9): 811-820.
|
29. |
Cribier A, Eltchaninoff H, Tron C, et al. Early experience with percutaneous transcatheter implantation of heart valve prosthesis for the treatment of end-stage inoperable patients with calcific aortic stenosis. J Am Coll Cardiol, 2004, 43(4): 698-703.
|
30. |
Khawaja MZ, Rajani R, Cook A, et al. Permanent pacemaker insertion after CoreValve transcatheter aortic valve implantation incidence and contributing factors (the UK CoreValve collaborative). Circulation, 2011, 123(9): U47-951.
|